Nalin Subasinghe is a Principal Scientist at Johnson & Johnson, where they focus on developing novel lead series aimed at treating diabetes and neuropathic pain within the metabolic therapeutic area. With prior experience as a Research Fellow at 3-Dimensional Pharmaceuticals, Nalin led teams in identifying preclinical candidates and contributed to the company's growth from 13 to 200 employees. Nalin holds a Bachelor of Science in Chemistry from the University of Colombo and is pursuing a Doctor of Philosophy in Medicinal Chemistry at the University of Minnesota-Twin Cities. They have a robust publication record, including 19 publications and over 16 patents, alongside expertise in drug discovery and structure-based drug design.
This person is not in the org chart
This person is not in any teams
This person is not in any offices